Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate and Ranibizumab
Determining the interaction of Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbetapentane / phenylephrine / potassium guaiacolsulfonate
Brand name:
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranibizumab Intraocular
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranibizumab ophthalmic
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranitidine
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranitidine Capsule
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranitidine Hydrochloride
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranitidine Injection
- Ranibizumab-Phenylephrine, Chlorpheniramine, and Carbetapentane Liquid
- Ranibizumab-Phenylephrine, Chlorpheniramine, and Chlophedianol Suspension
- Ranibizumab-Phenylephrine, Chlorpheniramine, and Codeine Syrup
- Ranibizumab-Phenylephrine, Dexchlorpheniramine, and Codeine
- Ranibizumab-Phenylephrine, Pyrilamine, and Chlophedianol Liquid
- Ranibizumab-Phenylephrine, Thonzylamine, and Dextromethorphan Liquid